Educational Webinar Library

Cardiovascular diseases are the leading cause of death in the United States and worldwide. In the light of the changing landscape of cardiac diseases epidemiology, conventional imaging techniques are no longer effective for diagnosis, risk assessment, and patient management . In contrast, quantitative PET provides absolute measurements that can help tackle these challenges and significantly improve patient care.    In this webinar, Dr Di Carli from Brigham and Women's Hospital and Dr. Buechel from University Hospital Zurich will explain why they believe PET imaging is the future in management of CVD.

Following up from last webinar, Vitor Alves from ICNAS at the University of Coimbra will describe the routine site activities and his long-standing experience in developing new processes with the Synthera®+ platform and IBA radiochemist experts will share the most recent developments on Synthera®+ platform including new [18F]FDOPA process, [18F]FES and [18F]Fapi-74.

The use of PET (Positron Emission Tomography) imaging is growing steadily worldwide. This technology is giving us new levels of precision and accuracy in oncology, cardiology and neurology. But starting a new radiopharmacy project can appear complex. In addition to handling the selection of hundreds of different pieces of equipment, materials and a highly-technical construction, there are numerous compliance and authorization procedures to follow. In this webinar, IBA’s experts will guide you through all the important steps to set up your GMP radiopharmacy. From the right questions to define your project and select your equipment to the support for quality assurance documentation/procedures, you will have a good overview to envision your future project. 

The clinical value of myocardial flow quantification is supported by numerous observational and clinical studies in various populations. Its use is no longer restricted to a few academic centers as the technology advances and guidelines evolves. In this webinar two leading figures in the field discussed the clinical value and practical aspects of PET quantification in cardiovascular imaging and why and how to implement this modality in your institution. What will you learn from the webinar? The practical aspects and clinical value of myocardial blood flow quantification in PET in patients with cardiovascular disease - By Piotr Slomka One of the most important advances in nuclear cardiology is the opportunity to quantify myocardial blood flow (MBF) and myocardial flow reserve (MFR) routinely as part of myocardial perfusion imaging (MPI) with PET. Dr. Slomka will review practical aspects of the MBF measurements with PET and discuss its clinical value in the management of cardiac patients. How to implement a cardiac PET myocardial perfusion imaging program ? (Due to the institution policy, the recording could not be shared) - By Sharmila Dorbala Dr. Dorbala will give an overview of the advantages of PET at identifying coronary artery disease (CAD), related workflow and current guidelines. She will also share her experience on how to implement a PET cardiac program.